Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Carnegie 530, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Nat Rev Cardiol. 2010 Mar;7(3):129-38. doi: 10.1038/nrcardio.2009.232.
Catheter ablation is an important treatment modality for patients with atrial fibrillation (AF). Although the superiority of catheter ablation over antiarrhythmic drug therapy has been demonstrated in middle-aged patients with paroxysmal AF, the role the procedure in other patient subgroups-particularly those with long-standing persistent AF-has not been well defined. Furthermore, although AF ablation can be performed with reasonable efficacy and safety by experienced operators, long-term success rates for single procedures are suboptimal. Fortunately, extensive ongoing research will improve our understanding of the mechanisms of AF, and considerable funds are being invested in developing new ablation technologies to improve patient outcomes. These technologies include ablation catheters designed to electrically isolate the pulmonary veins with improved safety, efficacy, and speed, catheters designed to deliver radiofrequency energy with improved precision, robotic systems to address the technological demands of the procedure, improved imaging and electrical mapping systems, and MRI-guided ablation strategies. The tools, technologies, and techniques that will ultimately stand the test of time and become the standard approach to AF ablation in the future remain unclear. However, technological advances are sure to result in the necessary improvements in the safety and efficacy of AF ablation procedures.
导管消融是心房颤动(AF)患者的重要治疗方式。尽管导管消融在中年阵发性 AF 患者中的疗效优于抗心律失常药物治疗,但该方法在其他患者亚组(尤其是持续性 AF 患者)中的作用尚未明确。此外,尽管经验丰富的操作者可以以合理的疗效和安全性进行 AF 消融,但单次手术的长期成功率并不理想。幸运的是,正在进行的广泛研究将提高我们对 AF 机制的理解,并且大量资金正在投入开发新的消融技术以改善患者的预后。这些技术包括旨在提高安全性、有效性和速度的用于电隔离肺静脉的消融导管、旨在提高精确度的用于传递射频能量的导管、用于解决手术技术需求的机器人系统、改进的成像和电描记图系统以及 MRI 引导的消融策略。未来成为 AF 消融标准方法的经得起时间考验的工具、技术和技术仍不清楚。然而,技术进步肯定会提高 AF 消融程序的安全性和有效性。